FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Russian Drone and Missile Attack Disrupts Power and Water in Kyiv 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Trump Says U.S. and NATO Will Reach Agreement on Greenland’s Future 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
France Nears 2026 Budget Deal as Government Offers Concessions to Avoid No-Confidence Vote 
Trump Administration Appeals Judge’s Order Limiting ICE Tactics in Minneapolis 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Trump’s Greenland Ambition Sparks NATO Tensions, Trade War Fears, and Global Market Turmoil 
Trump Declines G7 Paris Meeting Amid Rising Tensions With European Allies Over Greenland Remarks 
Syrian Government Consolidates Control as Kurdish Forces Withdraw from Key Regions 
Russian Air Attacks Plunge Kyiv Into Darkness, Raise Nuclear Safety Fears 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.
